Hydroxocobalamin and Jc virus infection - a phase IV clinical study of FDA data


Jc virus infection is reported only by a few people who take Hydroxocobalamin.

The phase IV clinical study analyzes which people take Hydroxocobalamin and have Jc virus infection. It is created by eHealthMe based on reports of 3,396 people who have side effects while taking Hydroxocobalamin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 08, 2022

3,396 people reported to have side effects when taking Hydroxocobalamin.
Among them, 5 people (0.15%) have Jc virus infection.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 3,424 Hydroxocobalamin users for its effectiveness, alternative drugs and more.

What is Jc virus infection?

Jc virus infection is found to be associated with 531 drugs and 274 conditions by eHealthMe.

Number of Hydroxocobalamin and Jc virus infection reports submitted per year:

Could Hydroxocobalamin cause Jc virus infection?

Gender of people who have Jc virus infection when taking Hydroxocobalamin *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Jc virus infection when taking Hydroxocobalamin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Hydroxocobalamin *:

  1. Folic Acid: 4 people, 80.00%
  2. Prednisolone: 3 people, 60.00%
  3. Mycophenolate Mofetil: 3 people, 60.00%
  4. Candesartan Cilexetil: 3 people, 60.00%
  5. Aspirin: 3 people, 60.00%
  6. Mycophenolic Acid: 1 person, 20.00%
  7. Acetylsalicylic Acid: 1 person, 20.00%

Common side effects people have besides Jc virus infection *:

  1. Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 5 people, 100.00%
  2. Locked-In Syndrome (a condition in which a patient is aware and awake but cannot move or communicate verbally due to complete paralysis): 5 people, 100.00%
  3. Cerebellar Syndrome (impaired blood circulation to cerebellum due to lesion in artery): 4 people, 80.00%
  4. Central Nervous System Lesion (an abnormality in tissue of brain or spinal cord): 4 people, 80.00%

Common conditions people have *:

  1. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 5 people, 100.00%
  2. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxocobalamin and have Jc virus infection?

Check whether Jc virus infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Jc virus infection and when was it recovered:

Expand to all the drugs that have ingredients of hydroxocobalamin:

Alternative drugs to, pros and cons of Hydroxocobalamin:

Common Hydroxocobalamin side effects:

Browse all side effects of Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Jc virus infection treatments and more:

COVID vaccines that are related to Jc virus infection:

Common drugs associated with Jc virus infection:

All the drugs that are associated with Jc virus infection:

Common conditions associated with Jc virus infection:

All the conditions that are associated with Jc virus infection:

How the study uses the data?

The study uses data from the FDA. It is based on hydroxocobalamin (the active ingredients of Hydroxocobalamin) and Hydroxocobalamin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: